M Gerstenhauer

824 citations
7 papers · 609 indexed · 1 hit paper · h-index 7

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 10%
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis

Papers in

M Gerstenhauer

7 papers receiving 591 citations

Hit Papers

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry 2013 · 434 citations
4342013202620172021100200300400

Peers

M Gerstenhauer
Comparison fields: 5 of 82
  • Cancer Research 259
  • Oncology 262
  • Dermatology 55
  • Pathology and Forensic Medicine 108
  • Immunology and Allergy 26
Replace Andrew P. Sciallis with:
Andrew P. Sciallis United States
Cha Kyong Yom South Korea
Yoshiaki Sagara Japan
Ali Küpelioğlu Türkiye
Myriam Kossaï France
Samanta Sarti Italy
Hongjian Yang China
J Sjöström Sweden
Christina Finlayson United States
Yasuhiro Yanagita Japan
M Gerstenhauer relative to Andrew P. Sciallis United States Andrew P. Sciallis's profile →
Citations per field
00.5×1.5×2.2×
Andrew P. Sciallis · 1×
Citations per year

Countries citing papers authored by M Gerstenhauer

Since Specialization
Citations

This map shows the geographic impact of M Gerstenhauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Gerstenhauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Gerstenhauer more than expected).

Fields of papers citing papers by M Gerstenhauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Gerstenhauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Gerstenhauer. The network helps show where M Gerstenhauer may publish in the future.

Co-authorship network

The 16 scholars most cited alongside M Gerstenhauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M Gerstenhauer Line = papers co-authored together M Gerstenhauer links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 201510
2 201549
3 201428
4
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
Hit paper breakdown →
2013434
5 200353
6
Dead Sea treatment - principle for outpatient use in atopic dermatitis: safety and efficacy of synchronous balneophototherapy using narrowband UVB and bathing in Dead Sea salt solution.
200313
7 200122

About M Gerstenhauer

M Gerstenhauer is a scholar working on Complementary and Manual Therapy, Complementary and alternative medicine, Cancer Research, Oncology and Dermatology, having authored 7 papers that have together received 609 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Complementary and Alternative Medicine Studies (3 papers), Breast Cancer Treatment Studies (3 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Cancer Cells and Metastasis (1 paper), Estrogen and related hormone effects (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Cancer Research (259 citations), Oncology (262 citations), Dermatology (55 citations), Pathology and Forensic Medicine (108 citations) and Immunology and Allergy (26 citations). M Gerstenhauer has collaborated with scholars based in Germany, Austria and Ireland. Frequent co-authors include Ferdinand Hofstädter, Michael Koller, Monika Klinkhammer‐Schalke, Olaf Ortmann, Florian Zeman, EC Inwald, R. Schiffner, Julia Schiffner-Rohe, M. Landthaler and W. Stolz. Their work appears in journals such as British Journal of Dermatology, Breast Cancer Research and Treatment, BioMed Research International, Journal of Cancer Research and Clinical Oncology and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026